F Dx Advisors, Inc. Dexcom Inc Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$75.49 - $124.16 $123,426 - $203,001	1,635 New	1,635 $203,000
Q2 2023 Jul 17, 2023	BUY	$112.47 - $130.98 $377,449 - $439,568	3,356 New	3,356 $431,000
Q2 2022 Aug 03, 2022	BUY	$67.99 - $132.89 $193,227 - $377,673	2,842 Added 365.3%	3,620 $270,000
Q1 2022 May 03, 2022	SELL	$94.08 - $130.2 $9,596 - $13,280	-102 Reduced 11.59%	778 $398,000
Q4 2021 Feb 01, 2022	BUY	$129.87 - $162.82 $114,285 - $143,281	880 New	880 $473,000
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $102,864 - $121,647	-1,077 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$62.68 - $105.34 $13,789 - $23,174	220 Added 25.67%	1,077 $437,000
Q1 2020 May 22, 2020	BUY	$47.79 - $75.63 $40,956 - $64,814	857 New	857 $231,000
Q3 2019 Nov 07, 2019	SELL	$35.53 - $43.8 $163,366 - $201,392	-4,598 Closed	0 $0
Q2 2019 Jul 19, 2019	BUY	$27.84 - $38.92 $14,281 - $19,965	513 Added 12.56%	4,598 $689,000
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $28,771 - $39,134	-1,025 Reduced 20.06%	4,085 $487,000
Q4 2018 Feb 07, 2019	BUY	$26.99 - $37.37 $59,458 - $82,326	2,203 Added 75.78%	5,110 $612,000
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $67,878 - $106,745	2,907 New	2,907 $416,000
Q2 2018 Aug 08, 2018	SELL	$17.54 - $25.22 $387,967 - $557,841	-22,119 Closed	0 $0
Q1 2018 May 02, 2018	SELL	$13.06 - $18.54 $12,433 - $17,650	-952 Reduced 4.13%	22,119 $1.64 Million
Q4 2017 Feb 09, 2018	BUY	$11.12 - $15.38 $64,095 - $88,650	5,764 Added 33.3%	23,071 $1.32 Million
Q3 2017 Nov 03, 2017	BUY	$11.36 - $18.98 $63,343 - $105,832	5,576 Added 47.53%	17,307 $847,000
Q2 2017 Aug 11, 2017	BUY	N/A	11,731	11,731 $858,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account